KB Biotech Solutions Plans $12 Million Manufacturing Complex in Dillon, South Carolina

SourceArea Development
Date Published10/27/2017
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name KB Biotech Solutions
Parent companyAnhui Chem-bright Bioengineering Co. Ltd.
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Total number of jobs (added or to be added):100
Year reshoring announced:2017
Year reshoring implemented or to be implemented:2018
Domestically, the work will be done:In-house
Capital investment ($):12
Country(ies) from which reshored:China
City reshored to:Dillon
State(s) reshored to:SC
If relevant, work nearshored to:-
Product(s) reshoredBiomedicine
What domestic positive factors made reshoring more attractive?Customer responsiveness improvement, Government Incentives, Infrastructure (transport, internet, power), Proximity to customers/market, Skilled workforce availability/training
Government Incentive dollar amount:$150,000 grant
Find Reshoring Articles